Thank you, Mr. Clark.
Maybe I'll just return to Trikafta, because the company has now been in application. I have a lot of constituents, as I think we all do, who want to see this drug approved and offered for public reimbursement in Canada. Has PMPRB looked at it already?
You said it was a $12-million cap for revenue. To me it sounds like—